To provide the best treatment for prostate and liver cancers and other diseases, Kintor Pharma is creating a diverse pipeline of combination therapies leveraging our innovative drugs.

After years of research and development, we have a balanced and diversified product pipeline with a strategic focus on dermatology and major cancers. Note: 1.In addition, IND for basal-cell carcinoma …

Kintor Pharma's product pipeline consists of six ongoing clinical products, including androgen receptor antagonists, AR-PROTAC, ALK-1 monoclonal antibody, Hedgehog/SMO inhibitor and mTOR inhibitor.

Currently, it has more than 10 preclinical projects in pipeline, focusing on research and development of tumor immunotherapy and tumor immune microenviroment-regulating antibody drugs.

Kintor Pharma's product pipeline consists of six ongoing clinical products, including androgen receptor antagonists, AR-PROTAC, ALK-1 monoclonal antibody, Hedgehog/SMO inhibitor and mTOR inhibitor.

As a Biotech company focusing on the R&D and industrialization of potential First-in-Class and Best-in-Class innovative drugs, Kintor Pharma has developed a diversified product pipeline including small …

Kintor Pharmaceutical Limited Announcements and circulars Focusing on the development and industrialization of potential "best-in-class" and "first-in-class" innovative drugs.

Kintor Pharmaceutical Limited is developing and commercializing a robust pipeline of innovative small molecule and biological therapeutics for androgen-receptor-related disease areas with unmet …

开拓药业成立于2009年，专注发展潜在“best-in-class”和“first-in-class”创新药物的研发及产业化，致力成为创新疗法研究、开发及商业化的领军企业。

Kintor Pharmaceuticals has prospectively deployed a diversified product pipeline that includes small molecule innovative drugs, bioinnovative drugs and combination therapies, including 5products that …